Dr. Reddy's Laboratories Allots 3,675 Equity Shares Under Employee Stock Option Plan
Dr. Reddy's Laboratories allotted 3,675 equity shares on March 26, 2026, to eligible employees under its ADR Stock Options Scheme, 2007. The shares were issued at two different exercise prices - 575 shares at Re.1/- each and 3,100 shares at Rs. 735.80/- each. Following this allotment, the company's total issued shares increased to 83,46,57,970 with corresponding share capital of Rs. 83,46,57,970/-. The newly allotted shares rank pari passu with existing shares and comply with SEBI regulations.
*this image is generated using AI for illustrative purposes only.
Dr. Reddy's Laboratories has announced the allotment of 3,675 equity shares to eligible employees under its employee stock option plan on March 26, 2026. The pharmaceutical company issued these shares pursuant to the exercise of stock options under Dr. Reddy's Employees ADR Stock Options Scheme, 2007.
Share Allotment Details
The company allotted equity shares with a par value of Re.1/- each, fully paid up, to employees who exercised their stock options. The allotment was structured at two different price points based on the exercise terms.
| Parameter: | Details |
|---|---|
| Total Shares Allotted: | 3,675 equity shares |
| Par Value: | Re.1/- each |
| Allotment Date: | March 26, 2026 |
| Scheme Name: | Dr. Reddy's Employees ADR Stock Options Scheme, 2007 |
| Distinctive Numbers: | 834653296 to 834656970 |
Exercise Price Structure
The shares were issued under a tiered pricing structure reflecting different exercise prices for the stock options:
| Share Category: | Number of Shares | Exercise Price | Premium |
|---|---|---|---|
| Category 1: | 575 shares | Re.1/- each | Nil premium |
| Category 2: | 3,100 shares | Rs. 735.80/- each | Rs. 734.80/- each |
Impact on Share Capital
Following this allotment, Dr. Reddy's Laboratories' equity structure has been updated. The total issued shares after this allotment stands at 83,46,57,970, with the corresponding total issued share capital amounting to Rs. 83,46,57,970/-.
The newly allotted shares rank pari passu with existing equity shares and carry identical rights and privileges. The shares have been issued in dematerialized form under ISIN number INE089A01031, and no lock-in restrictions apply to these shares.
Regulatory Compliance
The allotment was made in compliance with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The company has fulfilled all disclosure requirements under Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, and has notified all relevant stock exchanges where its shares are listed, including BSE Limited, National Stock Exchange of India Limited, New York Stock Exchange Inc., and NSE IFSC Limited.
Historical Stock Returns for Dr Reddys Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.64% | -6.41% | -5.36% | -2.20% | +5.65% | +32.67% |
How might this employee stock option exercise pattern indicate Dr. Reddy's employee confidence in the company's future performance and stock price trajectory?
What impact could the significant difference in exercise prices (Re.1 vs Rs.735.80) have on employee retention and motivation across different organizational levels?
Will Dr. Reddy's need to expand its existing ESOP schemes or introduce new employee incentive programs to maintain talent acquisition competitiveness in the pharmaceutical sector?
20
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
